(Q39340986)

11 September 2017

title

Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas (English)

1 reference

11 September 2017

Dong-Feng Niu

1

1 reference

11 September 2017

Tetsuo Kondo

2

1 reference

11 September 2017

Tadao Nakazawa

3

1 reference

11 September 2017

Naoki Oishi

4

1 reference

11 September 2017

Tomonori Kawasaki

5

1 reference

11 September 2017

Kunio Mochizuki

6

1 reference

11 September 2017

Tetsu Yamane

7

1 reference

11 September 2017

Ryohei Katoh

8

1 reference

11 September 2017

language of work or name

1 reference

28 May 2012

1 reference

11 September 2017

published in

Laboratory Investigation

1 reference

11 September 2017

volume

92

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

1181-1190

1 reference

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Epigenetic dysregulation in thyroid neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Regulation of skeletal development by the Runx family of transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Control of RUNX3 by histone methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Expression of human pendrin in diseased thyroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

8-Prenylkaempferol accelerates osteoblast maturation through bone morphogenetic protein-2/p38 pathway to activate Runx2 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Runx2 in normal tissues and cancer cells: A developing story.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Runx2 deficiency in mice causes decreased thyroglobulin expression and hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Runx2 in human breast carcinoma: its potential roles in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Runx2 regulates survivin expression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Extracellular nucleotides activate Runx2 in the osteoblast-like HOBIT cell line: a possible molecular link between mechanical stress and osteoblasts' response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

Expression of CD73 and its ecto-5'-nucleotidase activity are elevated in papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.84

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2012.84

1 reference

11 September 2017

1 reference